SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-22-000066
Filing Date
2022-05-17
Accepted
2022-05-17 16:14:00
Documents
14
Period of Report
2022-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bbi-20220517.htm   iXBRL 8-K 63104
2 EX-10.1 a202205178kex101.htm EX-10.1 164779
6 bbi-20220517_g1.jpg GRAPHIC 6568
  Complete submission text file 0000819050-22-000066.txt   414062

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20220517.xsd EX-101.SCH 1909
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20220517_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20220517_pre.xml EX-101.PRE 13055
8 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20220517_htm.xml XML 11253
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 22934648
SIC: 2836 Biological Products, (No Diagnostic Substances)